在肺动脉带状形成后,压缩左冠状动脉的Lecompte机动
Daisuke Takeyoshi1, Takeshi Konuma1, Ai Kojima1
1Department of Cardiovascular Surgery, Nagano Children's Hospital, Azumino, Japan.
Asian cardiovascular & thoracic annals
|September 20, 2023
概括
一种罕见的先天性心脏缺陷,包括由肺动脉压缩的高起飞左冠状动脉,通过勒康普特机动成功治疗. 这种干预在新生儿中解决了严重的心力衰竭.
科学领域:
- 心脏病学 心脏病学
- 儿科心脏手术 儿科心脏手术
- 遗传性心脏病是一种先天性心脏病.
背景情况:
- 完整心房隔膜缺陷是一种复杂的先天性心脏病.
- 肺动脉带纹是某些心脏缺陷的缓解性手术程序.
- 冠状动脉的高起飞是一种罕见的异常,可能与先天性心脏病有关.
研究的目的:
- 报告一个新生儿患有完整心室隔膜缺陷和未被诊断的左冠状动脉高起飞病例.
- 描述肺动脉带带后冠状动脉压缩引起的严重心力衰竭的管理.
- 为了突出莱科普特机动在治疗这种特殊复杂的先天性心脏异常方面的有效性.
主要方法:
- 一个月大的婴儿有完整的心室隔膜缺陷,经历了肺动脉带纹.
- 在术后发现左冠状动脉的高起飞率被右肺动脉扩张压缩,被右肺动脉压缩.
- 该患者因严重心力衰竭而接受莱科普特操作治疗.
主要成果:
- 莱科普特机动有效地缓解了高起飞的左冠状动脉的压力.
- 术后恢复表明,严重心力衰竭的成功治疗.
- 这一案例证明了在复杂的儿科心脏手术中考虑冠状动脉异常的重要性.
结论:
- 莱科普特操作是一种有效的手术选择,用于治疗新生儿患有先天性心脏缺陷的冠状动脉压缩后心力衰竭.
- 未被诊断的冠状动脉异常,如高起飞,可以导致心脏息性手术后的严重并发症.
- 早期识别和适当的外科纠正对于复杂的儿科先天性心脏病的良好结果至关重要.
相关概念视频
01:26Mitral Stenosis III: Medical Management
12
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
12
01:25Aortic Regurgitation III: Medical Management
24
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
24
01:27Coronary Artery Disease V: Interprofessional Care
9
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9